Outbreak of MRSA in a Gynecology/Obstetrics Department during the COVID-19 Pandemic: A Cautionary Tale.
Mareike MöllersMarie-Kristin von WahldeFranziska SchulerAlexander MellmannChristian BöingVera SchwierzeckJulia Sophie SchneiderStefanie KampmeierPublished in: Microorganisms (2022)
Since March 2020, the COVID-19 pandemic forced hospitals worldwide to intensify their infection control measures to prevent health care-associated transmission of SARS-CoV-2. The correct use of personal protective equipment, especially the application of masks, was quickly identified as priority to reduce transmission with this pathogen. Here, we report a nosocomial cluster of methicillin-resistant Staphylococcus aureus (MRSA) that occurred during the COVID-19 pandemic in a gynecology/obstetrics department, despite these intensified contact precautions. Five MRSA originating from clinical samples after surgical intervention led to an outbreak investigation. Firstly, this included environmental sampling of the operation theatre (OT) and, secondly, a point prevalence screening of patients and health care workers (HCW). All detected MRSA were subjected to whole genome sequencing (WGS) and isolate relatedness was determined using core genome multilocus sequence typing (cgMLST). WGS revealed one MRSA cluster with genetically closely related five patient and two HCW isolates differing in a single cgMLST allele at maximum. The outbreak was terminated after implementation of infection control bundle strategies. Although contact precaution measures, which are also part of MRSA prevention bundle strategies, were intensified during the COVID-19 pandemic, this MRSA outbreak could take place. This illustrates the importance of adherence to classical infection prevention strategies.
Keyphrases
- methicillin resistant staphylococcus aureus
- staphylococcus aureus
- healthcare
- sars cov
- randomized controlled trial
- end stage renal disease
- ejection fraction
- tertiary care
- type diabetes
- risk factors
- gene expression
- quality improvement
- prognostic factors
- metabolic syndrome
- coronavirus disease
- skeletal muscle
- multidrug resistant
- insulin resistance